Guggenheim Maintains Buy on Accolade, Lowers Price Target to $13
Portfolio Pulse from Benzinga Newsdesk
Guggenheim analyst Sandy Draper maintains a Buy rating on Accolade (NASDAQ:ACCD) but lowers the price target from $17 to $13.

May 08, 2024 | 5:25 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Guggenheim maintains a Buy rating on Accolade but lowers the price target from $17 to $13.
While the maintenance of a Buy rating indicates continued confidence in Accolade's fundamentals and potential for growth, the reduction in the price target could reflect adjustments in valuation metrics, market conditions, or expectations for the company's performance. This mixed signal might lead to short-term uncertainty among investors, balancing out potential positive and negative impacts on the stock price.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100